These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10713961)

  • 21. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
    Schwake M; Athanasiadu D; Beimgraben C; Blanz J; Beck C; Jentsch TJ; Saftig P; Friedrich T
    J Neurosci; 2006 Apr; 26(14):3757-66. PubMed ID: 16597729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells.
    Tatulian L; Brown DA
    J Physiol; 2003 May; 549(Pt 1):57-63. PubMed ID: 12702739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.
    Martire M; Castaldo P; D'Amico M; Preziosi P; Annunziato L; Taglialatela M
    J Neurosci; 2004 Jan; 24(3):592-7. PubMed ID: 14736843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly.
    Schwake M; Jentsch TJ; Friedrich T
    EMBO Rep; 2003 Jan; 4(1):76-81. PubMed ID: 12524525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels.
    Gamper N; Shapiro MS
    J Gen Physiol; 2003 Jul; 122(1):17-31. PubMed ID: 12810850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNE1 reverses the response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and sensitivity to temperature.
    Unsöld B; Kerst G; Brousos H; Hübner M; Schreiber R; Nitschke R; Greger R; Bleich M
    Pflugers Arch; 2000 Dec; 441(2-3):368-78. PubMed ID: 11211125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell.
    Selyanko AA; Hadley JK; Wood IC; Abogadie FC; Delmas P; Buckley NJ; London B; Brown DA
    J Neurosci; 1999 Sep; 19(18):7742-56. PubMed ID: 10479678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
    Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
    Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
    Main MJ; Cryan JE; Dupere JR; Cox B; Clare JJ; Burbidge SA
    Mol Pharmacol; 2000 Aug; 58(2):253-62. PubMed ID: 10908292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels.
    Lechner SG; Mayer M; Boehm S
    J Physiol; 2003 Dec; 553(Pt 3):789-802. PubMed ID: 14555721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current.
    Horowitz LF; Hirdes W; Suh BC; Hilgemann DW; Mackie K; Hille B
    J Gen Physiol; 2005 Sep; 126(3):243-62. PubMed ID: 16129772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of kcnq2 splice variants: implications to m current function during neuronal development.
    Smith JS; Iannotti CA; Dargis P; Christian EP; Aiyar J
    J Neurosci; 2001 Feb; 21(4):1096-103. PubMed ID: 11160379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two open states and rate-limiting gating steps revealed by intracellular Na+ block of human KCNQ1 and KCNQ1/KCNE1 K+ channels.
    Pusch M; Ferrera L; Friedrich T
    J Physiol; 2001 May; 533(Pt 1):135-43. PubMed ID: 11351022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
    Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
    Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular correlates of the M-current in cultured rat hippocampal neurons.
    Shah M; Mistry M; Marsh SJ; Brown DA; Delmas P
    J Physiol; 2002 Oct; 544(Pt 1):29-37. PubMed ID: 12356878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
    Zhang ZH; Lee YT; Rhodes K; Wang K; Argentieri TM; Wang Q
    Brain Res Mol Brain Res; 2003 Jul; 115(1):29-38. PubMed ID: 12824052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible link between KCNQ2- and STXBP1-related encephalopathies: STXBP1 reduces the inhibitory impact of syntaxin-1A on M current.
    Devaux J; Dhifallah S; De Maria M; Stuart-Lopez G; Becq H; Milh M; Molinari F; Aniksztejn L
    Epilepsia; 2017 Dec; 58(12):2073-2084. PubMed ID: 29067685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
    Wickenden AD; Yu W; Zou A; Jegla T; Wagoner PK
    Mol Pharmacol; 2000 Sep; 58(3):591-600. PubMed ID: 10953053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gq-Coupled Muscarinic Receptor Enhancement of KCNQ2/3 Channels and Activation of TRPC Channels in Multimodal Control of Excitability in Dentate Gyrus Granule Cells.
    Carver CM; Shapiro MS
    J Neurosci; 2019 Feb; 39(9):1566-1587. PubMed ID: 30593498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.
    Maljevic S; Lerche C; Seebohm G; Alekov AK; Busch AE; Lerche H
    J Physiol; 2003 Apr; 548(Pt 2):353-60. PubMed ID: 12640002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.